[Use of polyplatillen in chemotherapy of advanced pancreatic cancer].

Abstract

The results of Poliplatillen clinical application in 108 patients with advanced pancreatic cancer were analyzed. The use of Poliplatillen in adjuvant regimen improves the long-term results of treatment. The mean survival time was increased on 2.9 months, which was statistically significant, mediana survival was increased on 1.5 months, 10% of patients alived 20 months, 20%--16 months. Survival of patients of control group did not exceed 12 months.

• Authors: L D Iatsenko, S A Lial'kin, N M Maĭdanevych
• Journal: Klinichna khirurhiia (Klin Khir) Issue 7 Pg. 20-3 (Jul 2008) ISSN: 0023-2130 [Print] Ukraine
• PMID: 19048815 (Publication Type: English Abstract, Journal Article)

Chemical References

• DNA Adducts
• cisplatin-DNA adduct
• Cisplatin

Topics

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Cisplatin (therapeutic use)
• DNA Adducts (therapeutic use)
• Female
• Humans
• Male
• Middle Aged
• Neoplasm Staging
• Pancreatic Neoplasms (drug therapy, pathology)